Notably, the name change comes on the heels of Mirina's failed bid to sue Marina Biotech for trademark infringement due to its similar-sounding name.
A Marina official confirmed that neither company paid compensation to the other under the terms of the settlement.
In making its decision, the court said that Mirinia has “raised only serious questions” on the merits of its trademark infringement claim, and not shown that it would suffer “irreparable harm” if Marina is allowed to continue using its newly acquired moniker.
For instance, Tacere Therapeutics received $488,958 in two grants, the first of which supports development of a new hepatitis C treatment, as well as a previously undisclosed eye-disease program.
Adding to the difficulty in raising funds, there has also been an increase in the number of companies operating in the miRNA space in recent years, many of which are on the lookout for their share of available investment dollars.
Sep 30, 2010
Sep 23, 2010
Aug 19, 2010
Apr 29, 2010